Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 2
2006 2
2007 4
2008 7
2009 6
2010 5
2011 6
2012 5
2013 5
2014 9
2015 7
2016 9
2017 13
2018 8
2019 5
2020 13
2021 12
2022 14
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Women in brain-computer interfaces.
Lugo ZR, Cinel C, Jeunet C, Pichiorri F, Riccio A, Wriessnegger SC. Lugo ZR, et al. Among authors: pichiorri f. Front Hum Neurosci. 2023 Aug 22;17:1260479. doi: 10.3389/fnhum.2023.1260479. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37674934 Free PMC article. No abstract available.
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma.
Lewinsky H, Gunes EG, David K, Radomir L, Kramer MP, Pellegrino B, Perpinial M, Chen J, He TF, Mansour AG, Teng KY, Bhattacharya S, Caserta E, Troadec E, Lee P, Feng M, Keats J, Krishnan A, Rosenzweig M, Yu J, Caligiuri MA, Cohen Y, Shevetz O, Becker-Herman S, Pichiorri F, Rosen S, Shachar I. Lewinsky H, et al. Among authors: pichiorri f. JCI Insight. 2023 Jul 24;8(14):e173312. doi: 10.1172/jci.insight.173312. JCI Insight. 2023. PMID: 37485873 Free PMC article. No abstract available.
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation.
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM. Garofalo M, et al. Among authors: pichiorri f. Cancer Cell. 2022 Nov 14;40(11):1440. doi: 10.1016/j.ccell.2022.10.005. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306794 Free PMC article. No abstract available.
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia.
Murtadha M, Park M, Zhu Y, Caserta E, Dona AA, Singer M, Vahed H, Tasndoh T, Gonzalez A, Ly K, Sanchez JF, Chowdhury A, Pozhitkov A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams J, Pichiorri F. Murtadha M, et al. Among authors: pichiorri f. bioRxiv [Preprint]. 2023 Mar 1:2023.02.27.530273. doi: 10.1101/2023.02.27.530273. bioRxiv. 2023. PMID: 36909542 Free PMC article. Preprint.
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.
Awuah D, Minnix M, Caserta E, Tandoh T, Adhikarla V, Poku E, Rockne R, Pichiorri F, Shively JE, Wang X. Awuah D, et al. Among authors: pichiorri f. Cancer Immunol Immunother. 2023 Aug;72(8):2841-2849. doi: 10.1007/s00262-023-03461-z. Epub 2023 May 20. Cancer Immunol Immunother. 2023. PMID: 37209218 Free PMC article.
The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A, Hofmeister CC, Pichiorri F. Rocci A, et al. Among authors: pichiorri f. Expert Rev Mol Diagn. 2014 Nov;14(8):947-59. doi: 10.1586/14737159.2014.946906. Epub 2014 Aug 7. Expert Rev Mol Diagn. 2014. PMID: 25098410 Review.
138 results